Background: Microalbuminuria, a powerful predictor of cardiovascular events, is thought to reflect widespread subclinical vascular abnormalities. To explore the pathogenesis of increased urinary albumin excretion in primary hypertension we evaluated systemic capillary permeability and ambulatory blood pressure (BP) measurement in two groups of matched untreated patients with (n ϭ 11) and without (n ϭ 29) microalbuminuria.
M
icroalbuminuria has been shown to predict the risk of cardiovascular events or death in patients with primary hypertension. [1] [2] [3] Increased urinary albumin excretion (UAE) is often a concomitant of several unfavorable metabolic and nonmetabolic risk factors 4, 5 and indicates the presence of subclinical organ damage at the renal and cardiac level. 6, 7 Because of its unique ability to reflect many clinically relevant abnormalities, microalbuminuria is currently considered a marker of cardiovascular risk. However, the pathogenetic mechanisms underlying the development of increased UAE are still poorly understood.
According to the hypothesis originally proposed by Parving et al, 8 both the increase in blood pressure (BP) load and abnormal vascular permeability, possibly due to endothelial dysfunction, seem to concur with the development of microalbuminuria. 9 As a matter of fact, although increased systemic vascular permeability has been found in hypertensive patients with atherosclerosis or insulin resistance, 10, 11 the relationship between capillary permeability and UAE in patients with primary hypertension is still unclear. 10, 12, 13 The present study was therefore initiated in an attempt to clarify the relationship between BP, systemic capillary permeability, and albuminuria in patients with primary hypertension.
Methods

Subjects and Protocols
Between January 2000 and June 2002, all patients with primary hypertension attending the outpatient clinic of our institution were asked to participate in this study, which was part of a larger trial (MAGIC: Microalbuminuria: A Genoa Investigation on Complications). Details of the study have already been published.
14 Three hundred hypertensive patients were (consecutively) seen at our clinic within that time period. Among them 180 met the study criteria, including 18 patients with microalbuminuria. Among these patients, 11 (7 men and 4 women) agreed to participate and were defined as microalbuminurics. A control group was established from among the entire cohort of screened patients by selecting 33 hypertensive patients with normal albumin excretion matched for gender, age (Ϯ 5 years), and duration of hypertension (Ϯ 60 months). Twenty-nine patients (22 men and 7 women) accepted and make up the group of normoalbuminurics. The study protocol was approved by the Ethical Committee of our Department, and written informed consent was obtained from each subject. Both groups of hypertensive patients underwent complete physical examination and routine biochemical blood and urine analyses. Twenty-four-hour urine collection was obtained from each subject on the day before the study to assess dietary sodium intake and measure potassium and aldosterone levels. All patients were on a salt-unrestricted diet at the time of the study. The LDL cholesterol was calculated using Friedewald's formula. 15 Creatinine clearance was estimated by the Cockcroft-Gault formula. 16 Hypertension was defined as an average BP Ն140/90 mm Hg on at least three different occasions. Office BP was assessed by three consecutive readings and the average was recorded. Each patient also underwent a 24-h ambulatory BP recording (ABPM; Spacelabs Inc, Redmonds, WA). 17 Left arm readings were taken with a standard cuff during a 24-h period as described in Pontremoli et al. 6 The measurements were only taken into consideration if valid readings were no less than 80% of the expected readings, and if at least one valid reading per hour for at least 21 h was available. Systolic and diastolic BP load were defined as the percentage of BP readings that exceeded 130 and 80 mm Hg, respectively. Body mass index (BMI) was calculated using the formula: BMI ϭ weight (in kilograms)/height (in meters) squared. Family history for hypertension and cardiovascular disease, the amount of physical activity, smoking habits, and alcohol consumption were assessed by means of a standardized questionnaire. The presence and extent of left ventricular hypertrophy and microalbuminuria were assessed in all patients as described in Viazzi et al, 7 in agreement with European Society of Hypertension/European Society of Cardiology (ESH/ESC) guidelines. 18 Renal resistive index was assessed by ultrasound Doppler of the renal interlobar arteries, as described in Derchi et al.
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Transcapillary Escape Rate of Albumin
Patients were given oral iodine during the week preceding the bolus administration to prevent any uptake of 125 iodine by the thyroid gland. Free 125 I was eluted by passing the injection solution in a Sephadex G-25-M column (Column PD-10; Pharmacia, Uppsala, Sweden), a purification step that reduced free 125 I content in the injected dose to less than 1%. The 125 I-labeled human serum albumin (6 to 8 Ci, SARI-125 A-2; SORIN Biomedica, Saluggia, Italy) was injected as a bolus after a 30-min rest in the supine position and blood was withdrawn from the contralateral arm at 5, 10, 15, 20, 25, 30, 40, 50, 55 , and 60 min after the injection. Radioactivity was measured (Cobra 5000 ␥-counter; Packard, Downers Grove, IL) in duplicate in 1 mL of plasma for each sample. Transcapillary escape rate of albumin (TERalb) was expressed as the percentage decay per hour (%/h). The slope of the linear regression of radioactivity over time was used to calculate TERalb. One patient was excluded from the analysis because the correlation coefficient was lower than 0.85.
Renal Hemodynamics and Renin-Angiotensin-Aldosterone System Hormonal Pattern
We performed additional studies on a subset of 20 patients (10 patients with normoalbuminuria and 10 patients with microalbuminuria). On the morning of the study day, after an overnight fast and 30 min of rest in the supine position, blood was drawn to measure active renin and aldosterone. To evaluate glomerular filtration rate (GFR), 5 g of inulin (InutestR, Laevosan GmHB, Linz, Austria) was infused during 1 min. Blood samples were taken from the opposite arm at 0 (predosing), 2, 5, 10, 15, 20, 30, 45, 60, 90, 120, 150, 180, 210 , and 240 min after the end of the infusion.
Inulin in plasma samples was measured by means of the anthrone method after removing the glucose, essentially as described by Jung et al 20 and Orlando et al. 21 Renal clearance (GFR) was then calculated as the ratio of the amount excreted during the first 4 h to the corresponding area under the curve.
Para-aminohippurate (PAH) (Monico SPA, Mestre (Ve) Italy) was measured by standard chemical methods as described in Schnurr et al. 22 To measure renal plasma flow (RPF), PAH clearance was assessed by multiplying the infusion rate by the concentration in the infusate and dividing by the plasma concentration. The filtration fraction (FF) was calculated by expressing GFR as a percentage of RPF. Renal vascular resistance (RVR) was calculated by the Gomez formula: RVR ϭ (mean BP Ϫ 10)/RPF ϫ 60 ϫ 1322 ϫ (1 Ϫ hematocrit) as described in Zitta et al. 23 Plasma active renin was measured by radioimmunoassay (Sanofi Diagnostic Pasteur, Milan, Italy). Plasma and urine aldosterone were measured by radioimmunoassay (Sorin Biomedica, Saluggia, Italy).
Statistical Analysis
Data are mean Ϯ SD or percentage except for triglycerides, urinary albumin excretion, RPF, renin, and plasma aldosterone, which are expressed as the geometric mean and range. Differences among variables were assessed using the appropriate statistical test based on the underlying distribution of the variables. The Student t test was used to analyze the data of the two study groups for parametric distribution. The Mann-Whitney U test was used for data that were not distributed normally. Comparisons of proportion among groups were performed using the 2 test. Analysis of covariance (ANCOVA) was performed to analyze the association between TERalb and albuminuria, with BMI, 24-h mean BP, and left ventricular mass index (LVMI) as covariates. Relations among variables were assessed using linear regression analysis and Pearson's correlation coefficient. Logistic regression analysis was performed to assess the independent contribution of several variables (including TERalb and systolic BP) to the presence of microalbuminuria. All statistical analyses were performed using Statview for Windows (SAS Institute Inc., version 5.0.1, Cary, NC). P Ͻ .05 was considered statistically significant.
Results
The geometric mean of urinary albumin-to-creatinine ratio (ACR) was 6.1 mg/mmol (3.4 to 10.7 mg/mmol) and 0.3 mg/mmol (0.1 to 2.0 mg/mmol) in hypertensive patients with and without microalbuminuria, respectively ( Table 1) . As a consequence of the selection procedures at entry, age, gender, and known duration of disease were super-imposable between study groups. There were no significant differences between the two groups with regard to serum glucose, uric acid, creatinine, lipid profile, and intrarenal vascular resistance (Tables 1 and 2 ). Moreover, within the group of patients who underwent additional studies, we found no differences in renal hemodynamics or reninangiotensin-aldosterone system (RAAS) activities on the basis of UAE ( Table 2 ). The BMI, office systolic BP, as well as 24-h ambulatory systolic and diastolic BP values were higher in patients with microalbuminuria compared to those with normal UAE (Tables 1 and 2) . Furthermore, microalbuminuric patients showed higher LVMI (Table 1) and were more likely to have left ventricular hypertrophy than normoalbuminuric patients (odds ratio [OR] 6.7, 95% CI 1.5-30.7 , P ϭ .02). Finally, TERalb was significantly higher in patients with microalbuminuria compared to those without microalbuminuria, indicating an abnormal increase in vascular permeability (Fig. 1) . This result remained statistically significant even after adjusting for BMI, 24-h mean BP, and LVMI (ANCOVA, P Ͻ .05; data not shown).
Significant univariate correlations between urinary ACR or TERalb and selected clinical variables in the entire study group are shown in Tables 3 and 4 . Albuminuria did not correlate to BMI, lipid profile, or renal function, whereas it related to smoking habits and 24-h ambulatory systolic and diastolic BP values, signs of early cardiovascular damage, namely relative wall thickness and LVMI, and to TERalb (Table 3) . On the other hand, capillary permeability did not correlate to any BP components and was positively related only to triglyceride levels and albuminuria (Table 4) . Moreover, after adjusting for BMI, logistic regression analysis indicated that each 1% increment in TERalb or 10 mm Hg increase in systolic BP entailed an almost three times higher risk of being microalbuminuric (Table 5) .
Discussion
The present study shows that microalbuminuria is associated with greater BP load and vascular permeability in patients with primary hypertension. These findings may help understand the pathophysiologic mechanisms underlying the development of abnormal UAE and its association with increased cardiovascular mortality.
The development of microalbuminuria may reflect the interplay of several pathogenetic mechanisms that modulate systemic and renal BP load as well as vascular selectivity. The degree of BP elevation seems to be a major RWT ϭ relative wall thickness. other abbreviations as in Table 1 .
determinant of UAE. Pascual et al 24 defined the temporal relationship between BP and microalbuminuria by showing that the persistence of higher than normal systolic BP precedes the development of microalbuminuria in primary hypertension. Other studies, however, have shown contrasting data, indicating that the occurrence of microalbuminuria may precede the development of hypertension. 25 Furthermore, Mulè et al 26 used 24-h ambulatory BP monitoring to demonstrate a worse hemodynamic profile in patients with microalbuminuria. In our study patients, office BP readings were higher in patients with microalbuminuria (Tables 1 and 2 ). Twenty-four-hour ambulatory BP monitoring clearly showed that increased UAE is associated to a worse systemic BP profile, namely a lower BP daytime-to-night-time ratio, indicating the lack of a physiologic BP decrease during the night (Table 2) . Interestingly, linear regression analysis showed that ambulatory BP values correlated with UAE but not with TERalb (Tables 3 and 4 ). The latter finding is still under debate in the literature, with some studies reporting a linear correlation between TERalb and systolic but not diastolic and mean BP, 12, 13 and other studies failing to relate TERalb to ABPM indices. 10, 11 Whether microalbuminuric patients show an abnormal pattern of renal hemodynamics 27, 28 is currently a matter of debate. In the present study, we did not observe any differences in GFR, RPF, FF, and RVR in relation to the level of albuminuria (Table 2) , although we cannot rule out that these abnormalities might become visible with conditions such as dietary protein load. 23 Moreover, the activity of the RAAS might be implicated in the development of microalbuminuria. 29 Angiotensin II promotes efferent vasoconstriction and mesangial cell contraction, thus favoring the progressive appearance of microalbuminuria. Our study, however, does not confirm that RAAS activity is increased in association with microalbuminuria, at least at the systemic level ( Table 2 ). The UAE is not, however, only dependent on renal hemodynamic factors, but also on vascular selectivity. In fact, microalbuminuria may signal the presence of a more widespread abnormality of endothelial function at the systemic level. On the basis of this hypothesis, it has been shown that leakage of albumin through the glomerular membrane is paralleled by systemic, transvascular, macromolecular leakage, a process that represents the earliest stage of atherosclerosis. 9, 30 The latter observation is strengthened by the correlation we found between UAE and TERalb ( Table 4 , Fig. 1 ). Previous studies, mainly conducted on male patients with primary hypertension, 10, 12 showed a dissociation of these variables. The discrepancy with our findings could be partially due to the inclusion of women in our study population. In fact, the positive correlation between UAE and TERalb held true for women (P Ͻ .04) but not for men when analyzed separately. The lack of correlation between BP values and transvascular permeability in our study (Table 4) partly confirms previous studies on hypertensive patients that reported that BP elevation per se does not induce increased vascular permeability. In fact, Pedrinelli et al 10 described abnormal TERalb in patients with clinical atherosclerosis regardless of BP levels, and reported that patients with metabolic syndrome are characterized by higher transvascular permeability compared to essential hypertensives. 11 Altogether these data corroborate the belief that TERalb may be considered a marker of preclinical atherosclerosis, regardless of hemodynamic load. Recent data suggest that a subclinical inflammatory process might be related to the diffuse vascular dysfunction observed in patients with microalbuminuria. [31] [32] [33] Unfortunately, our study cannot help clarify this issue, as no data were collected on the inflammatory status of our patients. In the present study, multiple logistic regression analysis, including BMI in the model, showed an almost three times higher risk of being microalbuminuric for each 1% increment in TERalb and 10 mm Hg increase in 24-h systolic BP ( Table 5 ), suggesting that microalbuminuria is independently influenced by both systemic BP load and capillary permeability. In addition, hypertensive patients with microalbuminuria were characterized by significantly higher BP levels, early signs of target organ damage, and abnormal TERalb (Table 1, Fig. 1 ). These data are even more noteworthy when we consider that the two study BMI ϭ body mass index not significantly related to the presence of microalbuminuria; SBP ϭ systolic blood pressure. Other abbreviations as in Table 1 .
groups were matched for a number of potentially confounding variables such as age, gender, and duration of hypertension. As a result, patients were also similar as per lipid profile and renal function, which are known to influence UAE, endothelial permeability, and the development of target organ damage. Thus, although the cross sectional design of our study precludes any conclusion on the pathogenesis of increased albumin excretion rate, we believe our data support a separate role of BP and vascular permeability in explaining the presence of microalbuminuria.
In conclusion, by showing a close and independent relationship between UAE and BP load and TERalb, our study supports the view that microalbuminuria is an early renal manifestation of generalized vascular dysfunction, and may help explain its role as a predictor of cardiovascular events.
